Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,259,534
+$313,001 QoQ
Shares Held
14,785
+3.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#247
of 477 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $451,584,893 across 62 Biotechnology names. CYTK ranks #52 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
544,994 | $42,656,680 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
193,215 | $21,452,661 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
724,508 | $17,576,564 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
201,979 | $17,562,074 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
134,019 | $16,428,049 | |
| 6 | MGTX |
MeiraGTx Holdings plc
|
1,105,421 | $14,934,237 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
1,755,152 | $14,690,622 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
421,374 | $14,280,364 |
All Filings in CYTK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,259,534 | 14,785 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $946,533 | 14,361 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $837,647 | 13,183 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $715,634 | 13,021 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $220,409 | 6,671 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $261,476 | 6,506 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $302,137 | 6,423 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $277,252 | 5,251 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $243,593 | 4,496 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $223,791 | 3,192 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||